Skip to search.
 TSX Down 0.09% TSX Ventures Down 0.48%

XOMA Corporation (XOMA)

-NasdaqGM
3.42 Up 0.03(0.74%) May 22, 4:00PM EDT
Add to Portfolio
Prev Close:3.39
Open:3.38
Bid:3.32 x 500
Ask:3.52 x 100
1y Target Est:8.57
Beta:3.62
Earnings Date:Aug 5 - Aug 10 (Est.)
Day's Range:3.35 - 3.45
52wk Range:2.92 - 5.95
Volume:824,960
Avg Vol (3m):2,296,690
Market Cap:402.34M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XOMAUp 0.74%402.34M
NVSDown 0.90%251.35B
REGNDown 0.41%53.07B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.63
Quarterly EPS Est (Jun-15) :-0.18
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.28

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback